Literature DB >> 22873692

Minor activities and transition state properties of the human steroid hydroxylases cytochromes P450c17 and P450c21, from reactions observed with deuterium-labeled substrates.

Francis K Yoshimoto1, Yishan Zhou, Hwei-Ming Peng, David Stidd, Jennifer A Yoshimoto, Kamalesh K Sharma, Susan Matthew, Richard J Auchus.   

Abstract

The steroid hydroxylases CYP17A1 (P450c17, 17-hydroxylase/17,20-lyase) and CYP21A2 (P450c21, 21-hydroxylase) catalyze progesterone hydroxylation at one or more sites within a 2 Å radius. We probed their hydrogen atom abstraction mechanisms and regiochemical plasticity with deuterium-labeled substrates: 17-[(2)H]-pregnenolone; 17-[(2)H]-, 16α-[(2)H]-, 21,21,21-[(2)H(3)]-, and 21-[(2)H]-progesterone; and 21,21,21-[(2)H(3)]-17-hydroxyprogesterone. Product distribution and formation rates with recombinant human P450-oxidoreductase and wild-type human CYP17A1 or mutation A105L (reduced progesterone 16α-hydroxylation) and wild-type human CYP21A2 or mutation V359A (substantial progesterone 16α-hydroxylation) were used to calculate intramolecular and intermolecular kinetic isotope effects (KIEs). The intramolecular KIEs for CYP17A1 and mutation A105L were 4.1 and 3.8, respectively, at H-17 and 2.9 and 5.1, respectively, at H-16α. Mutation A105L 21-hydroxylates progesterone (5% of products), and wild-type CYP17A1 also catalyzes a trace of 21-hydroxylation, which increases with 16α-[(2)H]- and 17-[(2)H]-progesterone. The intramolecular KIEs with CYP21A2 mutation V359A and progesterone were 6.2 and 3.8 at H-21 and H-16α, respectively. Wild-type CYP21A2 also forms a trace of 16α-hydroxyprogesterone, which increased with 21,21,21-[(2)H(3)]-progesterone substrate. Competitive intermolecular KIEs paralleled the intramolecular KIE values, with (D)V values of 1.4-5.1 and (D)V/K values of 1.8-5.1 for these reactions. CYP17A1 and CYP21A2 mutation V359A both 16α-hydroxylate 16α-[(2)H]-progesterone with 33-44% deuterium retention, indicating stereochemical inversion. We conclude that human CYP17A1 has progesterone 21-hydroxylase activity and human CYP21A2 has progesterone 16α-hydroxylase activity, both of which are enhanced with deuterated substrates. The transition states for C-H bond cleavage in these hydroxylation reactions are either significantly nonlinear and/or asymmetric, and C-H bond breakage is partially rate-limiting for all reactions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22873692      PMCID: PMC3471366          DOI: 10.1021/bi300895w

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  45 in total

1.  Synthesis of halogenated pregnanes, mechanistic probes of steroid hydroxylases CYP17A1 and CYP21A2.

Authors:  Francis K Yoshimoto; Melissa C Desilets; Richard J Auchus
Journal:  J Steroid Biochem Mol Biol       Date:  2011-10-05       Impact factor: 4.292

2.  Three-dimensional structure of steroid 21-hydroxylase (cytochrome P450 21A2) with two substrates reveals locations of disease-associated variants.

Authors:  Bin Zhao; Li Lei; Norio Kagawa; Munirathinam Sundaramoorthy; Surajit Banerjee; Leslie D Nagy; F Peter Guengerich; Michael R Waterman
Journal:  J Biol Chem       Date:  2012-01-18       Impact factor: 5.157

Review 3.  The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders.

Authors:  Walter L Miller; Richard J Auchus
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

4.  Why human cytochrome P450c21 is a progesterone 21-hydroxylase.

Authors:  Dario Mizrachi; Zhu Wang; Kamalesh K Sharma; Manisha K Gupta; Keliang Xu; Christopher R Dwyer; Richard J Auchus
Journal:  Biochemistry       Date:  2011-04-21       Impact factor: 3.162

5.  Cytochrome P450 7A1 cholesterol 7alpha-hydroxylation: individual reaction steps in the catalytic cycle and rate-limiting ferric iron reduction.

Authors:  Raku Shinkyo; F Peter Guengerich
Journal:  J Biol Chem       Date:  2010-12-08       Impact factor: 5.157

6.  Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany.

Authors:  N Krone; A Braun; A A Roscher; D Knorr; H P Schwarz
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

7.  High-yield expression of a catalytically active membrane-bound protein: human P450 oxidoreductase.

Authors:  Duanpen Sandee; Walter L Miller
Journal:  Endocrinology       Date:  2011-05-17       Impact factor: 4.736

Review 8.  Human steroid biosynthesis for the oncologist.

Authors:  Mary Louise Auchus; Richard J Auchus
Journal:  J Investig Med       Date:  2012-02       Impact factor: 2.895

9.  Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001.

Authors:  Natasha M DeVore; Emily E Scott
Journal:  Nature       Date:  2012-01-22       Impact factor: 49.962

10.  A missense mutation in the human cytochrome b5 gene causes 46,XY disorder of sex development due to true isolated 17,20 lyase deficiency.

Authors:  Jan Idkowiak; Tabitha Randell; Vivek Dhir; Pushpa Patel; Cedric H L Shackleton; Norman F Taylor; Nils Krone; Wiebke Arlt
Journal:  J Clin Endocrinol Metab       Date:  2011-12-14       Impact factor: 5.958

View more
  21 in total

Review 1.  Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic.

Authors:  Richard J Auchus
Journal:  J Steroid Biochem Mol Biol       Date:  2016-02-06       Impact factor: 4.292

Review 2.  Rapid kinetic methods to dissect steroidogenic cytochrome P450 reaction mechanisms.

Authors:  Francis K Yoshimoto; Richard J Auchus
Journal:  J Steroid Biochem Mol Biol       Date:  2015-10-22       Impact factor: 4.292

3.  Instability of the Human Cytochrome P450 Reductase A287P Variant Is the Major Contributor to Its Antley-Bixler Syndrome-like Phenotype.

Authors:  Karen M McCammon; Satya P Panda; Chuanwu Xia; Jung-Ja P Kim; Daniela Moutinho; Michel Kranendonk; Richard J Auchus; Eileen M Lafer; Debashis Ghosh; Pavel Martasek; Rekha Kar; Bettie Sue Masters; Linda J Roman
Journal:  J Biol Chem       Date:  2016-08-05       Impact factor: 5.157

4.  Catalytically relevant electrostatic interactions of cytochrome P450c17 (CYP17A1) and cytochrome b5.

Authors:  Hwei-Ming Peng; Jiayan Liu; Sarah E Forsberg; Hong T Tran; Sean M Anderson; Richard J Auchus
Journal:  J Biol Chem       Date:  2014-10-14       Impact factor: 5.157

Review 5.  The hunt for a selective 17,20 lyase inhibitor; learning lessons from nature.

Authors:  Ian M Bird; David H Abbott
Journal:  J Steroid Biochem Mol Biol       Date:  2016-05-03       Impact factor: 4.292

6.  Human Cytochrome P450 21A2, the Major Steroid 21-Hydroxylase: STRUCTURE OF THE ENZYME·PROGESTERONE SUBSTRATE COMPLEX AND RATE-LIMITING C-H BOND CLEAVAGE.

Authors:  Pradeep S Pallan; Chunxue Wang; Li Lei; Francis K Yoshimoto; Richard J Auchus; Michael R Waterman; F Peter Guengerich; Martin Egli
Journal:  J Biol Chem       Date:  2015-04-08       Impact factor: 5.157

7.  Functional characterization of the G162R and D216H genetic variants of human CYP17A1.

Authors:  C P Capper; J Liu; L R McIntosh; J M Larios; M D Johnson; P F Hollenberg; Y Osawa; R J Auchus; J M Rae
Journal:  J Steroid Biochem Mol Biol       Date:  2017-12-09       Impact factor: 4.292

8.  Functional analysis of human cytochrome P450 21A2 variants involved in congenital adrenal hyperplasia.

Authors:  Chunxue Wang; Pradeep S Pallan; Wei Zhang; Li Lei; Francis K Yoshimoto; Michael R Waterman; Martin Egli; F Peter Guengerich
Journal:  J Biol Chem       Date:  2017-05-24       Impact factor: 5.157

9.  Inherent steroid 17α,20-lyase activity in defunct cytochrome P450 17A enzymes.

Authors:  Eric Gonzalez; Kevin M Johnson; Pradeep S Pallan; Thanh T N Phan; Wei Zhang; Li Lei; Zdzislaw Wawrzak; Francis K Yoshimoto; Martin Egli; F Peter Guengerich
Journal:  J Biol Chem       Date:  2017-12-06       Impact factor: 5.157

Review 10.  The diverse chemistry of cytochrome P450 17A1 (P450c17, CYP17A1).

Authors:  Francis K Yoshimoto; Richard J Auchus
Journal:  J Steroid Biochem Mol Biol       Date:  2014-12-04       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.